drugset / Trial / NCT01231698
Heart Rate Control With Esmolol in Septic Shock
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is investigate the effects on systemic hemodynamics and organ function of esmolol when used to maintain heart rate below a predefined threshold in patients with septic shock.
Timeline
- Start
- 2010-12
- Primary completion
- 2012-07
- Completion
- 2012-07
Publications
- Huang X, Zheng M, Zhu Z, Zhang Y, Chen KY. Association of anti-catecholaminergic antiarrhythmic drugs with survival in sepsis-associated new-onset atrial fibrillation. Sci Rep. 2026 Jul 6;16(1):20588. doi: 10.1038/s41598-026-51249-9.
- Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013 Oct 23;310(16):1683-91. doi: 10.1001/jama.2013.278477.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esmolol | Other / unclassified | — | Other |